BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7531704)

  • 1. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
    Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
    J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
    Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
    Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
    Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
    Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
    Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
    J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.
    Colamonici OR; Uyttendaele H; Domanski P; Yan H; Krolewski JJ
    J Biol Chem; 1994 Feb; 269(5):3518-22. PubMed ID: 8106393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homodimerization and intermolecular tyrosine phosphorylation of the Tyk-2 tyrosine kinase.
    Domanski P; Yan H; Witte MM; Krolewski J; Colamonici OR
    FEBS Lett; 1995 Nov; 374(3):317-22. PubMed ID: 7589562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.
    Barbieri G; Velazquez L; Scrobogna M; Fellous M; Pellegrini S
    Eur J Biochem; 1994 Jul; 223(2):427-35. PubMed ID: 8055912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.
    Yeh TC; Dondi E; Uze G; Pellegrini S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8991-6. PubMed ID: 10908660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
    Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
    J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
    Müller M; Briscoe J; Laxton C; Guschin D; Ziemiecki A; Silvennoinen O; Harpur AG; Barbieri G; Witthuhn BA; Schindler C
    Nature; 1993 Nov; 366(6451):129-35. PubMed ID: 8232552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
    Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of STAT2 in the alpha interferon signaling pathway.
    Leung S; Qureshi SA; Kerr IM; Darnell JE; Stark GR
    Mol Cell Biol; 1995 Mar; 15(3):1312-7. PubMed ID: 7532278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase.
    Gauzzi MC; Velazquez L; McKendry R; Mogensen KE; Fellous M; Pellegrini S
    J Biol Chem; 1996 Aug; 271(34):20494-500. PubMed ID: 8702790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-induced nuclear signalling by Jak protein tyrosine kinases.
    Silvennoinen O; Ihle JN; Schlessinger J; Levy DE
    Nature; 1993 Dec; 366(6455):583-5. PubMed ID: 7504785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
    Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
    J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression.
    David M; Zhou G; Pine R; Dixon JE; Larner AC
    J Biol Chem; 1996 Jul; 271(27):15862-5. PubMed ID: 8663536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.